News
$CureVac(CVAC.US$ CureVac Announces Phase 2 Interim Data From Seasonal Influenza Vaccine Development Program in Collaboration With GSK
Benzinga· 1 min ago
Benzinga· 1 min ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Nuyoah : The shorts have taken over
TrytosaveabitOP Nuyoah: I don’t think? Not yet anyway, I believe that’s some taking profit that we’re stuck and scalpers? Volume low yet! JMO
Nuyoah TrytosaveabitOP: Yes, it doesn't seem stable yet, right?
TrytosaveabitOP Nuyoah: Yup! Needs volume to see what it’s going to do?
Nuyoah TrytosaveabitOP: $阿索尔达生物 (ACOR.US)$ Is it worth entering here?
TrytosaveabitOP Nuyoah: Dangerous play! But if you are willing to risk for possible reward of bounce! Sure? NFA
Nuyoah TrytosaveabitOP: I'm a little afraid, it looks like it's still going to drop
TrytosaveabitOP Nuyoah: I believe so as well? But I’m keeping a eye on it!
Nuyoah TrytosaveabitOP: Recently, I've been choosing the wrong one. My losses are too big, and I'm starting to get nervousThanks for sharing, you're always great
TrytosaveabitOP Nuyoah: You got to really look at volume and the chart! Yes you might mis out on 10/15% on runners? But you can look for confirmation that way! Also if you enter quickly and it goes south? Cut your loses at a couple/few %! If it turns around and heads up? You can buy back in. It’s way easier to make up a 2/4% loss from selling and buying back, than holding for a 15%+ loss and then try to recover if it moves up! Hope this make sense? GL
View more comments...